Skip to main content
Clinical Trials/JPRN-jRCT1021230018
JPRN-jRCT1021230018
Not yet recruiting
未知

Prospective intervention study of swallowing function improvement anti-gastric ulcer drugs in the elderly.

Seki Yumika0 sites88 target enrollmentJuly 29, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Seki Yumika
Enrollment
88
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 29, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Seki Yumika

Eligibility Criteria

Inclusion Criteria

  • Elderly people aged 65 years or older with a history of gastric ulcer who have subjective symptoms of swallowing dysfunction or who have been diagnosed with swallowing dysfunction, and who are taking antacids.

Exclusion Criteria

  • 1\.Difficult to take gastric ulcer drugs due to severe dementia or deterioration of consciousness.
  • 2\.Patients with a history of limb amputation near the wrist or ankle.
  • 3\.Continuously taking test drugs (polaprezinc, rebamipide) for more than 1 week within 2 weeks before informed consent.
  • 4\.Have been hospitalized for more than 1 week within 2 weeks before informed consent.
  • 5\.Patients who are judged to be unsuitable to participate in this study by the principal investigator or co\-investigator.
  • 6\.Patients who are allergic to test drugs (polaprezinc, rebamipide) .
  • 7\.Patients who are judged to be difficult to participate in the study due to complication of psychosis or psychiatric symptoms.
  • 8\.Patients who are judged to be unable to perform the test due to severe dementia, etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials